Therapeutic RNAi robed with ionic liquid moieties as a simple, scalable prodrug platform for treating skin disease
- 1 November 2016
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 242, 80-88
- https://doi.org/10.1016/j.jconrel.2016.09.003
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1 S10 OD010610-01A1, 5R21CA19133-02)
This publication has 30 references indexed in Scilit:
- Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulationProceedings of the National Academy of Sciences, 2012
- Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancerProceedings of the National Academy of Sciences, 2011
- Therapeutic Effects on Atopic Dermatitis by Anti-RelA Short Interfering RNA Combined with Functional Peptides Tat and AT1002Journal of Pharmacology and Experimental Therapeutics, 2011
- MITF-siRNA Formulation Is a Safe and Effective Therapy for Human MelasmaMolecular Therapy, 2011
- Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model ratInternational Journal of Pharmaceutics, 2010
- Protective effect of pomegranate‐derived products on UVB‐mediated damage in human reconstituted skinExperimental Dermatology, 2009
- The burden of skin diseases: 2004Journal of the American Academy of Dermatology, 2006
- Current status and future potential of transdermal drug deliveryNature Reviews Drug Discovery, 2004
- Evaluation of the Pseudo-Absorption Method to Quantify Human Stratum corneum Removed by Tape Stripping Using Protein AbsorptionSkin Pharmacology and Physiology, 2003
- The Role of Elastases Secreted by Fibroblasts in Wrinkle Formation: Implication Through Selective Inhibition of Elastase Activity¶Photochemistry and Photobiology, 2001